Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prednisone and prednisolone are synthetic glucocorticoid corticosteroids used for their potent anti-inflammatory, immunosuppressive, and lymphocytotoxic properties. Prednisone is a prodrug that is rapidly converted by the liver into its active metabolite, prednisolone. In oncology, they are frequently utilized as components of multi-agent chemotherapy regimens for hematologic malignancies, such as classical Hodgkin Lymphoma (cHL), where they exert direct lymphocytotoxic effects by inducing apoptosis in malignant lymphoid cells. Their mechanism involves binding to the cytosolic glucocorticoid receptor (GR), which then translocates to the nucleus to modulate the transcription of genes involved in inflammation, cell survival, and cytokine production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on prednisone + prednisolone.